Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 117

1.

Remnant cholesterol as a causal risk factor for ischemic heart disease.

Varbo A, Benn M, Tybjærg-Hansen A, Jørgensen AB, Frikke-Schmidt R, Nordestgaard BG.

J Am Coll Cardiol. 2013 Jan 29;61(4):427-36. doi: 10.1016/j.jacc.2012.08.1026. Epub 2012 Dec 19.

PMID:
23265341
[PubMed - indexed for MEDLINE]
Free Article
2.

Elevated remnant cholesterol causes both low-grade inflammation and ischemic heart disease, whereas elevated low-density lipoprotein cholesterol causes ischemic heart disease without inflammation.

Varbo A, Benn M, Tybjærg-Hansen A, Nordestgaard BG.

Circulation. 2013 Sep 17;128(12):1298-309. doi: 10.1161/CIRCULATIONAHA.113.003008. Epub 2013 Aug 7.

PMID:
23926208
[PubMed - indexed for MEDLINE]
Free Article
3.

Nonfasting glucose, ischemic heart disease, and myocardial infarction: a Mendelian randomization study.

Benn M, Tybjaerg-Hansen A, McCarthy MI, Jensen GB, Grande P, Nordestgaard BG.

J Am Coll Cardiol. 2012 Jun 19;59(25):2356-65. doi: 10.1016/j.jacc.2012.02.043.

PMID:
22698489
[PubMed - indexed for MEDLINE]
Free Article
4.

Remnant cholesterol as a cause of ischemic heart disease: evidence, definition, measurement, atherogenicity, high risk patients, and present and future treatment.

Varbo A, Benn M, Nordestgaard BG.

Pharmacol Ther. 2014 Mar;141(3):358-67. doi: 10.1016/j.pharmthera.2013.11.008. Epub 2013 Nov 26. Review.

PMID:
24287311
[PubMed - indexed for MEDLINE]
5.

Genetically elevated non-fasting triglycerides and calculated remnant cholesterol as causal risk factors for myocardial infarction.

Jørgensen AB, Frikke-Schmidt R, West AS, Grande P, Nordestgaard BG, Tybjærg-Hansen A.

Eur Heart J. 2013 Jun;34(24):1826-33. doi: 10.1093/eurheartj/ehs431. Epub 2012 Dec 17.

PMID:
23248205
[PubMed - indexed for MEDLINE]
Free Article
6.

Combined analysis of six lipoprotein lipase genetic variants on triglycerides, high-density lipoprotein, and ischemic heart disease: cross-sectional, prospective, and case-control studies from the Copenhagen City Heart Study.

Wittrup HH, Andersen RV, Tybjaerg-Hansen A, Jensen GB, Nordestgaard BG.

J Clin Endocrinol Metab. 2006 Apr;91(4):1438-45. Epub 2006 Jan 17.

PMID:
16418216
[PubMed - indexed for MEDLINE]
7.

Low nonfasting triglycerides and reduced all-cause mortality: a mendelian randomization study.

Thomsen M, Varbo A, Tybjærg-Hansen A, Nordestgaard BG.

Clin Chem. 2014 May;60(5):737-46. doi: 10.1373/clinchem.2013.219881. Epub 2014 Jan 16.

PMID:
24436475
[PubMed - indexed for MEDLINE]
8.

Hepatic lipase, genetically elevated high-density lipoprotein, and risk of ischemic cardiovascular disease.

Johannsen TH, Kamstrup PR, Andersen RV, Jensen GB, Sillesen H, Tybjaerg-Hansen A, Nordestgaard BG.

J Clin Endocrinol Metab. 2009 Apr;94(4):1264-73. doi: 10.1210/jc.2008-1342. Epub 2008 Dec 16.

PMID:
19088157
[PubMed - indexed for MEDLINE]
9.

Nonfasting triglycerides and risk of ischemic stroke in the general population.

Freiberg JJ, Tybjaerg-Hansen A, Jensen JS, Nordestgaard BG.

JAMA. 2008 Nov 12;300(18):2142-52. doi: 10.1001/jama.2008.621.

PMID:
19001625
[PubMed - indexed for MEDLINE]
10.

Hepatic lipase mutations,elevated high-density lipoprotein cholesterol, and increased risk of ischemic heart disease: the Copenhagen City Heart Study.

Andersen RV, Wittrup HH, Tybjaerg-Hansen A, Steffensen R, Schnohr P, Nordestgaard BG.

J Am Coll Cardiol. 2003 Jun 4;41(11):1972-82.

PMID:
12798568
[PubMed - indexed for MEDLINE]
Free Article
11.

Nonfasting triglycerides and risk of myocardial infarction, ischemic heart disease, and death in men and women.

Nordestgaard BG, Benn M, Schnohr P, Tybjaerg-Hansen A.

JAMA. 2007 Jul 18;298(3):299-308.

PMID:
17635890
[PubMed - indexed for MEDLINE]
12.

Association of loss-of-function mutations in the ABCA1 gene with high-density lipoprotein cholesterol levels and risk of ischemic heart disease.

Frikke-Schmidt R, Nordestgaard BG, Stene MC, Sethi AA, Remaley AT, Schnohr P, Grande P, Tybjaerg-Hansen A.

JAMA. 2008 Jun 4;299(21):2524-32. doi: 10.1001/jama.299.21.2524.

PMID:
18523221
[PubMed - indexed for MEDLINE]
13.

Nonfasting cholesterol and triglycerides and association with risk of myocardial infarction and total mortality: the Copenhagen City Heart Study with 31 years of follow-up.

Langsted A, Freiberg JJ, Tybjaerg-Hansen A, Schnohr P, Jensen GB, Nordestgaard BG.

J Intern Med. 2011 Jul;270(1):65-75. doi: 10.1111/j.1365-2796.2010.02333.x. Epub 2010 Dec 27.

PMID:
21198993
[PubMed - indexed for MEDLINE]
14.

LCAT, HDL cholesterol and ischemic cardiovascular disease: a Mendelian randomization study of HDL cholesterol in 54,500 individuals.

Haase CL, Tybjærg-Hansen A, Qayyum AA, Schou J, Nordestgaard BG, Frikke-Schmidt R.

J Clin Endocrinol Metab. 2012 Feb;97(2):E248-56. doi: 10.1210/jc.2011-1846. Epub 2011 Nov 16.

PMID:
22090275
[PubMed - indexed for MEDLINE]
15.

Elevated Remnant Cholesterol in 25-Hydroxyvitamin D Deficiency in the General Population: A Mendelian Randomization Study.

Ooi EM, Afzal S, Nordestgaard BG.

Circ Cardiovasc Genet. 2014 Jul 27. pii: CIRCGENETICS.113.000416. [Epub ahead of print]

PMID:
25065375
[PubMed - as supplied by publisher]
16.

PCSK9 R46L, low-density lipoprotein cholesterol levels, and risk of ischemic heart disease: 3 independent studies and meta-analyses.

Benn M, Nordestgaard BG, Grande P, Schnohr P, Tybjaerg-Hansen A.

J Am Coll Cardiol. 2010 Jun 22;55(25):2833-42. doi: 10.1016/j.jacc.2010.02.044. Review.

PMID:
20579540
[PubMed - indexed for MEDLINE]
Free Article
17.

TRIB1 and GCKR polymorphisms, lipid levels, and risk of ischemic heart disease in the general population.

Varbo A, Benn M, Tybjærg-Hansen A, Grande P, Nordestgaard BG.

Arterioscler Thromb Vasc Biol. 2011 Feb;31(2):451-7. doi: 10.1161/ATVBAHA.110.216333. Epub 2010 Nov 11.

PMID:
21071687
[PubMed - indexed for MEDLINE]
Free Article
18.

Common cholesteryl ester transfer protein mutations, decreased HDL cholesterol, and possible decreased risk of ischemic heart disease: The Copenhagen City Heart Study.

Agerholm-Larsen B, Tybjaerg-Hansen A, Schnohr P, Steffensen R, Nordestgaard BG.

Circulation. 2000 Oct 31;102(18):2197-203.

PMID:
11056092
[PubMed - indexed for MEDLINE]
Free Article
19.

Loss-of-function mutations in APOC3 and risk of ischemic vascular disease.

Jørgensen AB, Frikke-Schmidt R, Nordestgaard BG, Tybjærg-Hansen A.

N Engl J Med. 2014 Jul 3;371(1):32-41. doi: 10.1056/NEJMoa1308027. Epub 2014 Jun 18.

PMID:
24941082
[PubMed - indexed for MEDLINE]
20.

Genetic inhibition of CETP, ischemic vascular disease and mortality, and possible adverse effects.

Johannsen TH, Frikke-Schmidt R, Schou J, Nordestgaard BG, Tybjærg-Hansen A.

J Am Coll Cardiol. 2012 Nov 13;60(20):2041-8. doi: 10.1016/j.jacc.2012.07.045. Epub 2012 Oct 17.

PMID:
23083790
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk